Predictors of Patient and Physician Assessments of Gout Control
Authors' conclusion
For both patients and physicians, absence of gout flares and serum urate levels at the treatment target predict assessment of gout control. However, discordance between patients and physicians in their assessment of disease control is not uncommon, with recent gout flares and tophus predicting lower scores by physicians than patients.
Study context
- Population
- Patients with gout taking allopurinol ≥300 mg daily
- Participants
- 223 patients
- Exposure
- Patient vs physician assessment of gout control
- Outcome
- Patient and physician assessments of current gout control (NRS 0-10) and predictors of discordance (absolute difference >2 units)
Methodological detailsstandardized gout assessment visit
- Standardized gout assessment visit
Main finding
As reported in the abstract
Gout control score (NRS 0-10)
Patient
8.09
mean · SD 2.24
Physician
7.38
mean · SD 2.63
P < 0.001 for comparison
Observational data: associations, not effects.
Further findings
Discordant patient–physician scores (absolute difference >2 units)
- Participants with discordant scores, mostly due to lower assessment by physicians
- 50 (22.3%)
- Gout flare in preceding 3 months predicting discordance (physician lower than patient), OR, P < 0.001
- 5.9
- Tophus predicting discordance (physician lower than patient), OR, P = 0.007
- 3.1
Original publication
Predictors of Patient and Physician Assessments of Gout Control. Arthritis Care Res (Hoboken). Published 28 December 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →